The
The Herz- und Diabeteszentrum Nordrhein-Westfalen (HDZ NRW) in Bad Oeynhausen is an internationally leading center for the treatment of heart, circulatory, and diabetes diseases. It has been a university hospital of the Ruhr University Bochum since 1989 and has also been part of the Medical Faculty OWL of Bielefeld University since 2023[1][3][5].
The mission of the HDZ NRW is to provide excellence in the prevention, diagnosis, therapy, and aftercare of heart, circulatory, and diabetes diseases. The focus is on interdisciplinary collaboration and state-of-the-art medical technology[1][3].
The HDZ NRW places great importance on continuing education and the promotion of research and development. It offers its employees comprehensive training programs and social benefits[4]. Additionally, the center emphasizes the importance of sustainability in medical care through efficient resource use and environmentally friendly practices, although specific sustainability initiatives are not explicitly mentioned.
The center treats approximately 36,000 patients annually, of which 14,500 are inpatient[3]. It has 500 planned beds and employs more than 2,500 staff[5]. The facility is operated by the Krankenhausbetriebsgesellschaft Bad Oeynhausen mbH, whose shares are 100% owned by the state of North Rhine-Westphalia[5].
